Lie T S
Surg Gynecol Obstet. 1976 Sep;143(3):369-75.
Sprague-Dawley rats were grafted with skin of Wistar rats. Surprisingly, pretreatment with donor-specific spleen homogenate and semisoluble antigens combined with prednisolone resulted in a prolonged survival of the skin grafts. The same effects were observed after transplantation of rabbit skin to Sprague-Dawley rats. Lewis rats were grafted with kidneys of LewisX brown-Norway F1 rats and simultaneously subjected to bilateral nephrectomy. The recipients were pretreated with soluble and with semisoluble donor-specific antigen. The recipients survived in definitely after pretreatment with semisoluble antigen combined with prednisolone. Combined administration of soluble antigen and prednisolone was ineffective. In the canine kidney allografts, the recipients were pretreated with semisoluble donor-specific spleen antigen; in the canine liver allografts, they were given soluble and semisoluble antigen. The canine kidney recipients survived significantly longer when they had been pretreated with antigens combined with high doses of prednisolone. Pretreatment with high doses of prednisolone alone did not prolong the survival of kidney grafted rats and dogs, and pretreatment with antigen alone had no effect on the survival of kidney grafted dogs. Pretreatment with antigen alone had no effect on the survival time of liver allografts in dogs, but the recipients of the liver grafts survived longer than and controls--some of them for more than 1,200 days--when they had been pretreated with antigens combined with prednisolone. In this respect, the semisoluble antigen was more effective than the soluble form. After three spaced antigen injections, the lymphocytotoxic antibody titers on the day of the grafting varied, but they were always low. There was no correlation between the titers on the day of transplantation and the duration of survival. Recipients pretreated with antigen showed lower postoperative antibody titers than those without antigen.
将Wistar大鼠的皮肤移植到Sprague-Dawley大鼠身上。令人惊讶的是,用供体特异性脾匀浆和半溶性抗原联合泼尼松龙进行预处理可使皮肤移植物的存活时间延长。将兔皮移植到Sprague-Dawley大鼠身上后也观察到了同样的效果。将LewisX棕色挪威F1大鼠的肾脏移植到Lewis大鼠身上,并同时进行双侧肾切除术。受体用可溶性和半溶性供体特异性抗原进行预处理。用半溶性抗原联合泼尼松龙预处理后,受体存活时间明显延长。可溶性抗原与泼尼松龙联合给药无效。在犬肾同种异体移植中,受体用半溶性供体特异性脾抗原进行预处理;在犬肝同种异体移植中,给受体注射可溶性和半溶性抗原。当用抗原联合高剂量泼尼松龙预处理时,犬肾移植受体的存活时间显著延长。单独用高剂量泼尼松龙预处理并不能延长肾移植大鼠和犬的存活时间,单独用抗原预处理对肾移植犬的存活没有影响。单独用抗原预处理对犬肝同种异体移植的存活时间没有影响,但当用抗原联合泼尼松龙预处理时,肝移植受体的存活时间比对照组更长——其中一些超过了1200天。在这方面,半溶性抗原比可溶性抗原更有效。在间隔注射三次抗原后,移植当天的淋巴细胞毒性抗体滴度各不相同,但始终较低。移植当天的滴度与存活时间之间没有相关性。用抗原预处理的受体术后抗体滴度低于未用抗原的受体。